Colorectal Cancer (CRC)

Oncology
3
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Immunophotonics
ImmunophotonicsMO - St. Louis
1 program
1
1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in waterPhase 2/31 trial
Active Trials
NCT07321847Not Yet RecruitingEst. Dec 2033
E
EisaiChina - Liaoning
1 program
1
E7070Phase 21 trial
Active Trials
NCT00165854Completed46
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
SC-007Phase 11 trial
Active Trials
NCT03253185Terminated7Est. Apr 2018
T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
total intravenous anaesthesiaN/A1 trial
Active Trials
NCT07237438RecruitingEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Immunophotonics1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water
EisaiE7070
AbbVieSC-007
T-Therapeuticstotal intravenous anaesthesia

Clinical Trials (4)

Total enrollment: 53 patients across 4 trials

NCT07321847Immunophotonics1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water

Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases

Start: May 2026Est. completion: Dec 2033
Phase 2/3Not Yet Recruiting
NCT00165854EisaiE7070

Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer

Start: Mar 200346 patients
Phase 2Completed
NCT03253185AbbVieSC-007

A Study of SC-007 in Subjects With Advanced Cancer

Start: Sep 2017Est. completion: Apr 20187 patients
Phase 1Terminated
NCT07237438T-Therapeuticstotal intravenous anaesthesia

TIVA Versus Balanced Anesthesia on Muscle Mass in CRC Surgery

Start: Sep 2025Est. completion: Jun 2026
N/ARecruiting

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
15m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
15m ago

Office Administrator

SystImmune
15m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
25m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
29m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
29m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 53 patients
4 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)